Compare CMCT & BNGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CMCT | BNGO |
|---|---|---|
| Founded | 1993 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Laboratory Analytical Instruments |
| Sector | Real Estate | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.1M | 12.5M |
| IPO Year | 1996 | 2018 |
| Metric | CMCT | BNGO |
|---|---|---|
| Price | $0.56 | $1.26 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | ★ 13.3M | 286.0K |
| Earning Date | 05-08-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 94.50 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $116,669,000.00 | $12,000,735.00 |
| Revenue This Year | N/A | $16.19 |
| Revenue Next Year | N/A | $33.34 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 26.26 |
| 52 Week Low | $0.06 | $1.06 |
| 52 Week High | $14.41 | $5.50 |
| Indicator | CMCT | BNGO |
|---|---|---|
| Relative Strength Index (RSI) | 41.30 | 56.32 |
| Support Level | $0.06 | $1.08 |
| Resistance Level | $0.85 | $1.64 |
| Average True Range (ATR) | 0.19 | 0.06 |
| MACD | 0.10 | 0.01 |
| Stochastic Oscillator | 21.69 | 84.37 |
Creative Media & Community Trust Corp is a Maryland corporation and REIT. It mainly acquires, develops, owns, and operates both multifamily properties situated in vibrant communities throughout the United States and Class A and creative office real assets in markets with similar business and employment characteristics to multifamily investments. All of its communities are located in areas that include traditional downtowns and suburban main streets, which have high barriers to entry, high population density, positive population trends, and a propensity for growth. Currently, the company consists of three types of commercial real estate properties, namely office, hotel, and multifamily.
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.